J. Fang

Publications269
h-index48
Citations11,695
Highly Influential Citations263
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • S. Solomon
  • 956 Publications • 62,967 Citations
  • J. McMurray
  • 1,090 Publications • 80,244 Citations
  • C. O'connor
  • 1,137 Publications • 62,877 Citations
  • M. Pfeffer
  • 785 Publications • 117,156 Citations
  • Publications
  • Influence
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice…
Jeffrey L. Anderson, MD, FACC, FAHA, Chair; Alice K. Jacobs, MD, FACC, FAHA, Immediate Past Chair; Jonathan L. Halperin, MD, FACC, FAHA, Chair-Elect; Nancy M. Albert, PhD, CCNS, CCRN, FAHA; Ralph G.… Expand
  • 3,253
  • 50
  • PDF
Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure.
OBJECTIVES This study was designed to determine the relevance of a proposed classification for advanced heart failure (HF). Profiles based on clinical assessment of congestion and perfusion at the… Expand
  • 519
  • 18
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials
ContextImplantable cardioverter defibrillator (ICD) therapy is effective in primary and secondary prevention of sudden cardiac death among patients with prior myocardial infarction and depressed… Expand
  • 249
  • 10
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
OBJECTIVES This study was designed to compare the safety and efficacy of veno-venous ultrafiltration and standard intravenous diuretic therapy for hypervolemic heart failure (HF) patients. … Expand
  • 677
  • 9
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure
Background—Soluble ST2 reflects activity of an interleukin-33–dependent cardioprotective signaling axis and is a diagnostic and prognostic marker in acute heart failure. The use of ST2 in chronic… Expand
  • 294
  • 9
Heart Failure With Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes
Background— We hypothesized that patients with heart failure (HF) who recover left ventricular function (HF-Recovered) have a distinct clinical phenotype, biology, and prognosis compared with… Expand
  • 138
  • 9
  • PDF
Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
BACKGROUND Cardiac resynchronization therapy (CRT) is effective in reducing clinical events in systolic heart failure patients with a wide QRS. Previous retrospective studies suggest only patients… Expand
  • 199
  • 8
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.
  • J. Fang, Y. Shing, +6 authors M. Moses
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences…
  • 11 April 2000
Among the earliest and most important stages during tumorigenesis is the activation of the angiogenic process, an event that is termed the "switch to the angiogenic phenotype." We have developed an… Expand
  • 376
  • 7
  • PDF
Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction: Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure…
Background—Abnormalities in cardiac structure and function in heart failure with preserved ejection fraction may help identify patients at particularly high risk for cardiovascular morbidity and… Expand
  • 144
  • 7
Multiple Biomarkers for Risk Prediction in Chronic Heart Failure
Background—Prior studies have suggested using a panel of biomarkers that measure diverse biological processes as a prognostic tool in chronic heart failure. Whether this approach improves risk… Expand
  • 162
  • 6
  • PDF
...
1
2
3
4
5
...